STAT+: Pharmalittle: We’re reading about a review of Alzheimer’s drugs, FDA interest in compounded peptides, and more
The FDA will convene an outside panel of advisers to discuss whether to allow compounding pharmacies to manufacture certain peptides
By STAT News
· Apr 16, 2026
· via STAT News
Image: STAT News
Tags
theweekformat:headlineheadlineSTAT News
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekSTAT News ↗
“These sides aren't talking to each other. And there's a lot riding on it”: The hosts of “Why Should I Trust Y…
The WeekBriefing
KFF’s new weekly podcast debuts April 2026, diving into healthcare’s financial and policy mechanics, starting …
The WeekBriefing
Drug Channels’ April roundup highlights how vertical integration and copay maximizers are changing the economi…